SCHEMBL6447649

SCHEMBL6447649

Cc1ccc(C(=O)c2[c]ccc(C(C)C)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
LMNA P02545 2/20 0.46
SRD5A2 P31213 2/20 0.41
CNR1 P21554 2/20 0.38
CNR2 P34972 2/20 0.38
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
GAA P10253 2/20 0.36
HTT P42858 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
SCN5A Q14524 1/20 0.36
SCN2A Q99250 1/20 0.36
AKR1C3 P42330 1/20 0.36
MAPT P10636 2/20 0.36
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
RXRG P48443 1/20 0.36
RAB9A P51151 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3209323 0.82 ALDH1A1 (0.54) ALDH1A1LMNASRD5A2CNR1CNR2
SCHEMBL26490140 0.74 ALDH1A1 (0.70) ALDH1A1LMNASRD5A2CNR1CNR2
SCHEMBL24600462 0.72 MAPT (0.59) ALDH1A1LMNASRD5A2SMN1; SMN2HTT
SCHEMBL315202 0.71 ALDH1A1 (0.54) ALDH1A1LMNASRD5A2CES2CES1
SCHEMBL16601079 0.70 ALDH1A1 (0.45) ALDH1A1SRD5A2CNR1CNR2CES2
SCHEMBL564584 0.68 LMNA (0.34) ALDH1A1LMNASMN1; SMN2HTTMAPT
SCHEMBL28727133 0.66 ALDH1A1 (0.70) ALDH1A1LMNASRD5A2CNR1CNR2
SCHEMBL52200 0.66 ALDH1A1 (1.00) ALDH1A1LMNASRD5A2CES2CES1
SCHEMBL822185 0.66 ALDH1A1 (1.00) ALDH1A1LMNASRD5A2CES2CES1
SCHEMBL28787119 0.66 CNR1 (0.55) ALDH1A1LMNASRD5A2CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050043369-A1 Bactericidal antimicrobial methods and compositions for use in treating gram positive infections PROTEZ PHARMACEUTICALS INC. (US) 2005-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043369-A1 Bactericidal antimicrobial methods and compositions for use in treating gram positive infections NAAA, TLR8, OPA1 ALDH1A1 2191/4885LMNA 3860/4885SRD5A2 3648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.